The UK pharma industry saw a spike in public trust and favourability amid the COVID-19 pandemic that, so far, shows little sign of wearing off, according to a new poll.
In amongst a report on healthcare practitioners’ attitude to biopharma companies is the disappointing finding that only 45% of them feel they embody patient centricity at
People who trust pharma are more interested in using the industry’s services – making building confidence in the sector key to realising the potential of patient centricity.
In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho